• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

风险差异的自举法和二阶检验

Bootstrap and second-order tests of risk difference.

作者信息

Lloyd Chris J

机构信息

University of Melbourne, Carlton, Australia.

出版信息

Biometrics. 2010 Sep;66(3):975-82. doi: 10.1111/j.1541-0420.2009.01354.x.

DOI:10.1111/j.1541-0420.2009.01354.x
PMID:19912176
Abstract

Clinical trials data often come in the form of low-dimensional tables of small counts. Standard approximate tests such as score and likelihood ratio tests are imperfect in several respects. First, they can give quite different answers from the same data. Second, the actual type-1 error can differ significantly from nominal, even for quite large sample sizes. Third, exact inferences based on these can be strongly nonmonotonic functions of the null parameter and lead to confidence sets that are discontiguous. There are two modern approaches to small sample inference. One is to use so-called higher order asymptotics (Reid, 2003, Annal of Statistics 31, 1695-1731) to provide an explicit adjustment to the likelihood ratio statistic. The theory for this is complex but the statistic is quick to compute. The second approach is to perform an exact calculation of significance assuming the nuisance parameters equal their null estimate (Lee and Young, 2005, Statistic and Probability Letters 71, 143-153), which is a kind of parametric bootstrap. The purpose of this article is to explain and evaluate these two methods, for testing whether a difference in probabilities p(2) - p(1) exceeds a prechosen noninferiority margin δ(0) . On the basis of an extensive numerical study, we recommend bootstrap P-values as superior to all other alternatives. First, they produce practically identical answers regardless of the basic test statistic chosen. Second, they have excellent size accuracy and higher power. Third, they vary much less erratically with the null parameter value δ(0) .

摘要

临床试验数据通常以小计数的低维表格形式呈现。标准的近似检验,如得分检验和似然比检验,在几个方面存在不足。首先,它们对相同的数据可能给出截然不同的答案。其次,即使对于相当大的样本量,实际的一类错误也可能与名义值有显著差异。第三,基于这些检验的精确推断可能是零假设参数的强非单调函数,并导致不连续的置信集。有两种现代的小样本推断方法。一种是使用所谓的高阶渐近性(Reid,2003年,《统计学年鉴》31卷,第1695 - 1731页)对似然比统计量进行显式调整。其理论很复杂,但统计量计算很快。第二种方法是在假设干扰参数等于其零假设估计值的情况下进行显著性的精确计算(Lee和Young,2005年,《统计与概率快报》71卷,第143 - 153页),这是一种参数自举法。本文的目的是解释和评估这两种方法,用于检验概率差异p(2) - p(1)是否超过预先选定的非劣效性界值δ(0)。基于广泛的数值研究,我们推荐自举P值优于所有其他方法。首先,无论选择何种基本检验统计量,它们给出的答案几乎相同。其次,它们具有出色的大小准确性和更高的功效。第三,它们随零假设参数值δ(0)的变化波动要小得多。

相似文献

1
Bootstrap and second-order tests of risk difference.风险差异的自举法和二阶检验
Biometrics. 2010 Sep;66(3):975-82. doi: 10.1111/j.1541-0420.2009.01354.x.
2
Choice of delta noninferiority margin and dependency of the noninferiority trials.δ非劣效界值的选择及非劣效性试验的依赖性
J Biopharm Stat. 2007;17(2):279-88. doi: 10.1080/10543400601177384.
3
Blinded sample size recalculation for clinical trials with normal data and baseline adjusted analysis.针对具有正态数据和基线调整分析的临床试验进行盲法样本量重新计算。
Pharm Stat. 2011 Jan-Feb;10(1):8-13. doi: 10.1002/pst.398.
4
A ratio test in active control non-inferiority trials with a time-to-event endpoint.具有事件发生时间终点的活性对照非劣效性试验中的比值检验。
J Biopharm Stat. 2006;16(2):151-64. doi: 10.1080/10543400500508754.
5
A more powerful exact test of noninferiority from binary matched-pairs data.一种基于二元匹配对数据的更强大的非劣效性精确检验。
Stat Med. 2008 Aug 15;27(18):3540-9. doi: 10.1002/sim.3229.
6
Use of the Fieller-Hinkley distribution of the ratio of random variables in testing for noninferiority.在非劣效性检验中使用随机变量比率的菲勒 - 欣克利分布。
J Biopharm Stat. 2007;17(2):215-28. doi: 10.1080/10543400601177335.
7
Test for the consistency of noninferiority from multiple clinical trials.多个临床试验的非劣效性一致性检验。
J Biopharm Stat. 2007;17(2):265-78. doi: 10.1080/10543400601177400.
8
Futility interim monitoring with control of type I and II error probabilities using the interim Z-value or confidence limit.使用期中 Z 值或置信限控制 I 型和 II 型错误概率的无效性期中监测。
Clin Trials. 2009 Dec;6(6):565-73. doi: 10.1177/1740774509350327. Epub 2009 Nov 23.
9
Statistical inference of risk difference in K correlated 2 x 2 tables with structural zero.具有结构零的K个相关2×2列联表中风险差异的统计推断。
Pharm Stat. 2009 Oct-Dec;8(4):317-32. doi: 10.1002/pst.360.
10
Sample size adaptation in fixed-dose combination drug trial.固定剂量复方药物试验中的样本量调整
J Biopharm Stat. 2012;22(4):679-86. doi: 10.1080/10543406.2012.676533.

引用本文的文献

1
Physical activity in recurrent colon cancer: Cancer and Leukemia Group B/SWOG 80702 (Alliance).复发性结肠癌中的体力活动:癌症和白血病组 B/SWOG 80702(联盟)。
Cancer. 2023 Dec 1;129(23):3724-3734. doi: 10.1002/cncr.35007. Epub 2023 Aug 31.
2
Association between physical activity and the time course of cancer recurrence in stage III colon cancer.体力活动与 III 期结肠癌复发时间进程的关系。
Br J Sports Med. 2023 Aug;57(15):965-971. doi: 10.1136/bjsports-2022-106445. Epub 2023 Mar 6.
3
Physical Activity in Stage III Colon Cancer: CALGB/SWOG 80702 (Alliance).
III 期结肠癌患者的体力活动:CALGB/SWOG 80702(Alliance)。
J Clin Oncol. 2023 Jan 10;41(2):243-254. doi: 10.1200/JCO.22.00171. Epub 2022 Aug 9.